A woman may arrive at a routine visit with irregular periods, a history of gestational diabetes, darkened skin at the neck, rising triglycerides, and fatigue after meals. Each detail has several possible causes. Together, they make a glucose-risk assessment more useful than a guess based on weight or one symptom.
Insulin resistance means that muscle, fat, and liver cells respond less effectively to insulin, the hormone that helps move glucose from blood into cells. The pancreas can compensate for years by releasing more insulin. Blood glucose may remain in the normal range during that period, which helps explain why insulin resistance often has no obvious symptoms.
The Most Common Symptom Is No Symptom
The National Institute of Diabetes and Digestive and Kidney Diseases states that insulin resistance and prediabetes usually cause no symptoms. Fatigue, cravings, difficulty losing weight, brain fog, and sleepiness after eating circulate widely online as “signs,” but none can diagnose insulin resistance. Anemia, thyroid disease, sleep loss, medication effects, depression, menopause symptoms, and many other conditions can produce the same experiences.
Physical findings can strengthen the case for testing. Acanthosis nigricans causes thicker, darker, velvety skin, often around the neck, armpits, or groin. Skin tags can occur alongside it, although they are common for other reasons. High blood pressure, high triglycerides, low HDL cholesterol, increasing waist circumference, and fatty liver disease also cluster with insulin resistance.
Frequent urination, marked thirst, blurry vision, unexplained weight loss, recurrent infections, or slow-healing wounds can signal that blood glucose has already reached a diabetes range. These symptoms call for prompt medical evaluation rather than an online insulin-resistance quiz.
Women’s Life Stages Change the Clues
Hormonal transitions do not cause the same metabolic response in every woman. Pregnancy, polycystic ovary syndrome (PCOS), menopause, sleep changes, and shifts in body composition can alter insulin sensitivity or reveal risk that was already present.
PCOS Connects Reproductive and Metabolic Health
PCOS can involve irregular ovulation, higher androgen levels, acne, excess facial or body hair, and fertility difficulty. Insulin resistance is common in PCOS and can increase the risk of type 2 diabetes and cardiovascular disease. The American College of Obstetricians and Gynecologists also notes the association with acanthosis nigricans and metabolic syndrome.
Irregular periods alone do not establish either PCOS or insulin resistance. Thyroid disorders, high prolactin, perimenopause, under-fueling, intense training, pregnancy, and other conditions can disrupt cycles. A useful evaluation considers menstrual history, androgen-related symptoms, pregnancy goals, medications, blood pressure, lipids, and glucose testing rather than treating the cycle as a standalone metabolic test.
Pregnancy Creates a Natural Stress Test
Insulin resistance rises during pregnancy as placental hormones help direct fuel toward the fetus. Some people cannot produce enough additional insulin and develop gestational diabetes. The Centers for Disease Control and Prevention reports that about half of women with gestational diabetes later develop type 2 diabetes.
A past pregnancy therefore belongs in today’s medical history, even when glucose returned to normal after delivery. Current guidelines recommend postpartum testing and continued screening. Before another pregnancy, preconception glucose assessment can identify a problem early enough to reduce maternal and fetal risk.
Midlife Can Shift Body Composition
During the menopause transition, some women gain abdominal fat, lose muscle, sleep poorly, or become less active because of symptoms and competing demands. Those changes can reduce insulin sensitivity. Menopause does not make worsening glucose inevitable, and thin women can also develop insulin resistance. Family history, ethnicity, prior gestational diabetes, PCOS, medications, sleep apnea, and liver fat still shape risk.
Routine Care Tests Glucose Regulation
Direct tests of insulin resistance are used mainly in research. In ordinary care, clinicians usually look for prediabetes or diabetes and assess the surrounding metabolic pattern. The NIDDK’s clinical guide to diabetes and prediabetes testing explains how fasting glucose, A1C, and the oral glucose tolerance test are used and when an abnormal result needs confirmation. PCOS, acanthosis nigricans, gestational-diabetes history, fatty liver disease, hypertension, abnormal lipids, and family history all add context to screening decisions.
Common tests include:
- A1C: estimates average glucose exposure over roughly three months. Prediabetes is generally 5.7% to 6.4%.
- Fasting plasma glucose: measures glucose after an overnight fast. Prediabetes is generally 100 to 125 mg/dL.
- Oral glucose tolerance test: measures the response to a glucose drink. A two-hour result of 140 to 199 mg/dL is generally in the prediabetes range outside pregnancy.
- Lipid panel and blood pressure: show related cardiovascular and metabolic risk.
- Liver assessment: may be appropriate when enzymes, imaging, or risk factors suggest fatty liver disease.
Diagnostic thresholds and pregnancy testing protocols differ, and one abnormal result may need confirmation. A1C can also be misleading with some anemias, hemoglobin variants, kidney disease, recent blood loss, transfusion, or pregnancy. The test should fit the person.
Fasting insulin and calculated scores such as HOMA-IR are sometimes ordered by specialty clinics. Assays and cutoffs are not standardized well enough to serve as a universal diagnosis. A high or normal insulin value must be interpreted with glucose, timing, laboratory method, and clinical context. Repeating a panel of expensive insulin measurements may add less value than addressing a clear pattern of prediabetes, PCOS, hypertension, abnormal lipids, or liver fat.
Build a Plan Around the Driver
For many women, the first treatment layer is regular movement, adequate sleep, a food pattern rich in minimally processed plants and useful protein sources, and gradual weight change when excess body fat is contributing. Resistance training supports muscle, which is a major site for glucose use. Walking or other movement after meals can also help the body handle glucose.
The plan should account for constraints. Pelvic-floor symptoms, arthritis, caregiving, night-shift work, menopause symptoms, food access, and a history of disordered eating can change what is safe and sustainable. A rigid diet that cannot survive those conditions will have limited value.
Medication may be appropriate for diagnosed prediabetes, diabetes, PCOS symptoms, obesity, or related conditions, but the choice depends on pregnancy plans, contraception, kidney and liver function, side effects, and other medicines. Do not start metformin, a GLP-1 drug, or a supplement based on symptoms alone. Some weight-loss and glucose-lowering drugs require advance planning before pregnancy.
A Practical Testing Conversation
Bring a timeline of menstrual changes, pregnancies, gestational-diabetes results, weight or waist changes, sleep, medications, family history, and recent laboratory values. Ask which glucose test fits now, whether PCOS or another hormonal condition needs evaluation, and when normal testing should be repeated.
Our guides to metabolic syndrome criteria and reading a blood panel can help organize the surrounding measurements. The central decision is whether the full pattern warrants testing and follow-up. Symptoms alone rarely settle the question, while the right blood tests and history can expose risk early enough to change its course.